SJ
Sanjay Jhamb
About Sanjay Jhamb
Data last updated:
Sanjay Jhamb is a Director at Raymed Ophthalmic Private Limited (since 2019) and Additional Director at Raycure Drugs Limited (since 2020). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹26.05 Cr; the largest is Raymed Ophthalmic Private Limited at ₹25.60 Cr (FY 2025). Earlier, Sanjay Jhamb was a Director at Raymed Pharmaceuticals Limited (2016–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 May 2019 | 2019 | ₹25.60 Cr (FY 2025) | Active | |
| Additional Director | 31 Aug 2020 | 2006 | ₹45.2 Lakh (FY 2017) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Nov 2016 | 1995 | ₹14.90 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Jhamb
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Sachdeva | 08068960 | Raymed Ophthalmic Private Limited | Director |
| Sanjiv Kumar Kansal | 08521073 | Raymed Ophthalmic Private Limited | Additional Director |
| Shivansh Sharma | 07159961 | Raymed Ophthalmic Private Limited | Director |
| Tarsem Kumar Ruby | 00957764 | Raymed Ophthalmic Private Limited , Raycure Drugs Limited | Director |
| Veeta Sharma | 00957852 | Raycure Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Jhamb
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Jhamb
Sanjay Jhamb currently holds 2 directorships: Raymed Ophthalmic Private Limited (Director, since 02 May 2019, revenue ₹25.60 Cr (FY 2025)); Raycure Drugs Limited (Additional Director, since 31 Aug 2020, revenue ₹45.2 Lakh (FY 2017)).
Sanjay Jhamb was first appointed on 08 Nov 2016 as Director at Raymed Pharmaceuticals Limited. The most recent appointment on record is 31 Aug 2020 at Raycure Drugs Limited.
The 2 current companies of Sanjay Jhamb that report revenue have a combined latest revenue of ₹26.05 Cr: Raymed Ophthalmic Private Limited ₹25.60 Cr (FY 2025); Raycure Drugs Limited ₹45.2 Lakh (FY 2017).
Sanjay Jhamb held 1 earlier board appointment: Raymed Pharmaceuticals Limited (Director, 08 Nov 2016 to 06 Dec 2022).
The current boards of Sanjay Jhamb's companies include Ashish Sachdeva (Raymed Ophthalmic Private Limited), Sanjiv Kumar Kansal (Raymed Ophthalmic Private Limited), Shivansh Sharma (Raymed Ophthalmic Private Limited), Tarsem Kumar Ruby (Raymed Ophthalmic Private Limited), Veeta Sharma (Raycure Drugs Limited).